Brief: Singapore Edevelopment Says U.S. Unit Has Product Which Shows Efficacy Against Tuberculosis
28/01/2019 24:29
Jan 28 (Reuters) - Singapore eDevelopment Ltd SINE.SI :
* U.S. BIOMEDICAL UNIT HAS A PRODUCT KNOWN AS 3F
ANTIMICROBIAL
FRAGRANCE WHICH SHOWS EFFICACY AGAINST TUBERCULOSIS
Source text for Eikon: urn:newsml:reuters.com:*:nSNZ7gd5TK
Further company coverage: SINE.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alset International
See all newsSingapore's Alset International half-year revenue rises sharply on food and beverage business
Brief: Alset International Posts HY Loss Attributable S$4.5 Million
Brief: Alset International Announces Formation Of Joint Venture
Brief: Alset International Posts HY Loss Attributable From Continuing Operations Of S$14.1 Mln
Brief: Alset International Says Entered Two Stock Purchase Agreements